Bruker today announced that it has acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL). Headquartered in Heidelberg, Germany, Luxendo was founded in September 2015. The company develops and manufactures proprietary light-sheet fluorescence microscopy instruments. Luxendo’s proprietary single plane illumination microscopy (SPIM) technique significantly reduces sampling times over conventional laser scanning confocal microscopes, while reducing phototoxicity and damaging side effects on living specimens.
The SPIM microscopes significantly enhance Bruker’s existing portfolio of swept-field confocal, super-resolution, and multiphoton fluorescence microscope product lines, enabling new research advances in small organism embryology, live-cell imaging, brain development and cleared brain tissue, and optogenetics applications. This acquisition is another important step forward in Bruker’s portfolio transformation the company says.